The EIC Accelerator is a highly competitive grant program that supports innovative startups and SMEs in Europe. The venture's focus on predicting drug resistance mutations from protein sequence alone aligns with the program's emphasis on strategic technologies for Europe. With a strong proof-of-concept validated and a clear roadmap, the venture is well-positioned to apply for this grant.